1. Genentech

    0 Comments Leave a Comment

    1-6 of 6

    1. Mentioned In 6 Articles

    2. Assessment of Differential Pharmacodynamic Effects Using Optical Coherence Tomography in Neovascular Age-Related Macular Degeneration

      Explore iovs.org (Mar 9 2012) Journal Articles

      ...e. To use novel OCT parameters in assessing the differential pharmacodynamic effects of bevacizumab (Avastin; Genentech, South San Francisco, CA), pegaptanib (Macugen; OSI Pharmaceuticals, New York, NY), and verteporfin ... (Read Full Article)

      Mentions:   Genentech

    3. Bevacizumab versus Ranibizumab — The Verdict

      Explore The New England Journal of Medicine (Apr 28 2011) Journal Articles , AMD , Retina

      ...wo anti-VEGF drugs most commonly used are bevacizumab (Avastin) and ranibizumab (Lucentis), both developed by Genentech. Bevacizumab, a full-length humanized monoclonal antibody, has been approved by the Food and Drug Ad... (Read Full Article)

      Mentions:   Bascom Palmer Eye Institute   Genentech

    4. Anatomic and Visual Outcomes of Vitrectomy for VitreomacularTraction Syndrome

      Explore Ophthalmic Surgery, Lasers and Imaging (Jul 8 2010) Journal Articles

      ...f Medicine and in part by a departmental grant from Massachusetts Lions. Dr. Duker is a consultant for Alcon, Genentech, and Ophthotech, is a scientific advisor for Paloma Pharmaceuticals, and receives research support f... (Read Full Article)

      Mentions:   Carl Zeiss Meditec   New England Eye Center   Genentech

    5. Anatomic and Visual Outcomes of Vitrectomy for Lamellar MacularHoles

      Explore Ophthalmic Surgery, Lasers and Imaging (Jul 8 2010) Journal Articles , Retina

      ...f Medicine and in part by a departmental grant from Massachusetts Lions. Dr. Duker is a consultant for Alcon, Genentech, and Ophthotech, is a scientific advisor for Paloma Pharmaceuticals, and receives research support f... (Read Full Article)

      Mentions:   Carl Zeiss Meditec   New England Eye Center   Genentech

    6. Insights into Advanced Retinopathy of Prematurity Using Handheld Spectral Domain Optical Coherence Tomography Imaging

      Explore OphSource (Sep 17 2009) Journal Articles , Retina

      ...utes of Health, North Carolina Biotechnology Center, and Sirion; is a consultant for Alcon Laboratories and Genentech; and receives royalties for ophthalmic surgical technologies through a Duke University agreement wit... (Read Full Article)

      Mentions:   Duke University   Genentech

    7. Who will pay for the trial’s drugs? NEI Awaits CMS Policy Decision on AMD Clinical Trial

      Explore Optometric Management (Apr 15 2007) News

      ...d Services (CMS) on whom should pay for the drugs [ran-izumab (Lucentis, Genentech) and bevacizumab (Avastin, Genentech)]. AMD study background In October 2006, the NEI an-nounced it would fund a multicenter, four–ar... (Read Full Article)

      Mentions:   National Institute of Health   Genentech   Gerson, Jeffry D. OD

    8. 1-6 of 6